Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    CAPS Gross Margin

    As of 2025-05-21, the Gross Margin of Capstone Holding Corp (CAPS) is 84.8%.

    Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

    CAPS Gross Margin - Historical Value
    DateValue
    2019-12-31 84.8%
    2018-12-31 87.5%
    2017-12-31 -
    2016-12-31 -
    2015-12-31 -
    2014-12-31 -
    2013-12-31 -
    2012-12-31 -
    2011-12-31 -
    2010-12-31 -
    CAPS Gross Margin - Peers Comparison
    TickerNameValue
    AMBSAmarantus Bioscience Holdings Inc7775.2%
    ANTHAnthera Pharmaceuticals Inc7775.2%
    ARNIArno Therapeutics Inc7775.2%
    BIEIPremier Graphene Inc9.9%
    BSSPBaseline Productions Inc7775.2%
    ENDVEndonovo Therapeutics Inc92.6%
    FPMIFluoroPharma Medical Inc88.2%
    HSTCHST Global Inc-11.4%
    IMUCEom Pharmaceutical Holdings Inc7775.2%
    MBI.H.VMany Bright Ideas Technologies Inc7775.2%
    NNBPNanobac Pharmaceuticals Inc16.7%
    OBMPTheralink Technologies Inc71%
    OMMHOmnimmune Holdings Inc7775.2%
    OVITOncovista Innovative Therapies Inc7775.2%
    PANCPanacos Pharmaceuticals Inc100%
    PARDPoniard Pharmaceuticals Inc-
    PLPLPlandai Biotechnology Inc-216%
    PPCBPropanc Biopharma Inc7775.2%
    PROTStromacel Inc102%
    PRTXProtalex Inc-
    SPHSSophiris Bio Inc-
    TLOGTetraLogic Pharmaceuticals Corp7775.2%
    TNGNQTengion Inc7775.2%
    VIAPVIA Pharmaceuticals Inc100%
    WWHCW World Corp7775.2%
    XENOXeno Transplants Corp-
    Tickers added to watchlist